Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
Title/Summary: The tender titled 'Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Tocilizumab' is issued by AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, located in Erfurt, Germany. It aims to establish non-exclusive discount agreements for the drug Tocilizumab through an Open-House model, with a contract duration ending no later than July 31, 2028.
Scope Of Work: This tender involves the establishment of non-exclusive discount agreements for the pharmaceutical product Tocilizumab (ATC-Code: L04AC07) as per § 130a Abs. 8 SGB V. The agreements will be made available to all interested pharmaceutical companies during the participation period, provided they meet the eligibility criteria. The quantities required are not guaranteed and will depend on various factors such as demand and prescribing behavior. Interested companies can access the participation documents through the German Procurement Portal (DTVP) after submitting a request for access. Confidentiality regarding the content of the participation documents is mandated, and any materials must be securely destroyed if participation is declined. The first submission deadline for applications is December 2, 2026, with further deadlines available in the project room.
Qualification Criterion: Bidders must be pharmaceutical companies that meet the specified participation criteria outlined in the project documents available on the DTVP. They are required to maintain confidentiality regarding the content of the participation documents, especially concerning the discount agreements. All submitted documents must comply with data protection regulations, and bidders must destroy any materials if they decide not to participate. The tender also specifies that late submissions will be considered in the next application period.
Purchaser contact is for registered users
Login to see detailsTender details are for registered users
Login to see details| Tender | Country | TOT Ref. No. | Bid deadline |
|---|---|---|---|
| Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Drugs with the Active Ingredient Combination of Brinzolamide and Brimonidine (Atc Code: S01ec24). | Germany | 152718425 | 27 Oct 2028 |
| Hygiene Material Nationwide | Germany | 152713573 | 21 Dec 2026 |
| Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Medicines with the Active Ingredient Lisdexamfetamine (Atc Code: N06ba12, Without Hard Capsules in a Pack Size of 30). | Germany | 152712954 | 27 Oct 2028 |
| Supply of Urological Medical Devices and Consumables ** | Germany | 152712716 | 18 Dec 2026 |
| Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Medicines with the Active Ingredient Hydrocortisone (Atc Code: H02ab09). | Germany | 152708510 | 27 Oct 2028 |